7th India-Japan Symposium on Medical Products Regulation7th India-Japan Symposium on Medical Products Regulation New Delhi, India July 14, 2024 The 7th India-Japan Symposium on Medical Products Regulation was held in New Delhi, India, under the Memorandum of Cooperation (MoC) between the two countries. The symposium brought together around 200 delegates, including government officials, regulatory authorities, and industry representatives. The event focused on promoting cooperation in regulatory matters for medical products, including pharmaceuticals, medical devices, and biological products-biosimilars. The delegates discussed emerging topics such as: * Enhancements to the MoC * Regulatory updates and best practices * Exchange of insights in pharmaceuticals, medical devices, and regenerative medicines The opening session featured presentations from: * Rajiv Wadhawan, Joint Secretary, MoHFW * Dr. Rajeev Singh Raghuvanshi, DCGI, CDSCO * Yada Shinji, Executive Director, PMDA * Dr. Hirota Mitsue, Deputy Director, MHLW * Dr. Ranga Chandrashekar, JDCI, CDSCO The discussions centered around improving regulatory practices, facilitating trade, and ensuring the safety and efficacy of medical products in both countries. The symposium concluded with a joint statement reiterating the commitment of India and Japan to enhance cooperation in the field of medical product regulation.
7th India-Japan Symposium on Medical Products Regulation held in New Delhi
By: IPP Bureau
Last updated: July 14, 2024 3:41 PM
Enhanced cooperation under the Memorandum of Cooperation (MoC) between India and Japan in the area of regulatory affairs for medical products
The 7th India-Japan Medical Product Regulatory Symposium, organised by the Central Drugs Standard Control Organisation (CDSCO) under the Ministry of Health & Family Welfare, Government of India, was successfully held at New Delhi. The event was held in accordance with the Memorandum of Cooperation (MoC) between India and Japan, aimed at promoting cooperation in regulatory matters for medical products.
The symposium brought together around 200 delegates from the Ministry of Health and Family Welfare, India, and the Ministry of Health, Law and Welfare, Japan. Regulatory authorities from CDSCO, India, and PMDA, Japan, along with representatives from the pharmaceutical, medical devices and biological products-biosimilars sectors, actively participated in constructive discussions.
The MoC, originally signed in December 2015 by CDSCO and the Japanese Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceutical and Medical Devices Agency (PMDA), emphasises mutual cooperation in the field of medical product regulation until December 2025. These regulatory symposia are held alternately in India and Japan and serve as crucial platforms for exchanging insights and improving regulatory practices.
The symposium featured insightful presentations from Indian and Japanese drug regulatory authorities followed by in-depth discussions on emerging topics in pharmaceuticals, medical devices and regenerative medicines. These deliberations were crucial in educating industry stakeholders on the latest regulatory initiatives in both countries.
The opening session of the symposium was graced by distinguished dignitaries including Rajiv Wadhawan, Joint Secretary, MoHFW; Dr. Rajeev Singh Raghuvanshi, DCGI, CDSCO; Yada Shinji, Executive Director, PMDA; Dr. Hirota Mitsue, Deputy Director, MHLW, and Dr. Ranga Chandrashekar, JDCI, CDSCO. The event attracted participation of 80 drug regulators and 120 industry representatives from India and Japan, leading to fruitful exchanges on regulatory updates and best practices.
